Golden Biotechnology Corporation (TPEX:4132)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.00
+3.15 (15.87%)
At close: Dec 5, 2025

Golden Biotechnology Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
3,7312,5235,5828,54817,1236,459
Upgrade
Market Cap Growth
29.21%-54.81%-34.69%-50.08%165.10%66.72%
Upgrade
Enterprise Value
3,9982,7375,5148,16317,0026,556
Upgrade
Last Close Price
23.0015.1635.9655.07118.6543.73
Upgrade
PS Ratio
83.6961.6588.0139.24209.4172.72
Upgrade
PB Ratio
19.598.2513.8811.1816.537.34
Upgrade
P/TBV Ratio
23.169.1014.9111.6217.007.63
Upgrade
EV/Sales Ratio
89.6866.9086.9337.48207.9473.81
Upgrade
Debt / Equity Ratio
1.721.200.680.370.280.29
Upgrade
Asset Turnover
0.080.060.070.170.060.08
Upgrade
Inventory Turnover
0.890.720.630.600.380.28
Upgrade
Quick Ratio
0.230.640.751.751.791.79
Upgrade
Current Ratio
0.540.921.142.282.572.94
Upgrade
Return on Equity (ROE)
-146.06%-101.91%-61.99%-30.20%-46.33%-50.09%
Upgrade
Return on Assets (ROA)
-33.90%-31.13%-25.14%-14.32%-19.83%-20.12%
Upgrade
Return on Capital (ROIC)
-35.86%-33.19%-26.52%-15.60%-21.51%-21.44%
Upgrade
Return on Capital Employed (ROCE)
-117.60%-94.80%-85.30%-37.00%-39.40%-37.00%
Upgrade
Earnings Yield
-8.44%-14.30%-6.48%-3.18%-2.59%-6.06%
Upgrade
FCF Yield
-6.41%-10.47%-4.95%-3.04%-1.21%-4.17%
Upgrade
Buyback Yield / Dilution
-12.93%-5.90%--7.36%-5.40%-9.32%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.